Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Targovax ASA: Invitation to third quarter 2016 results presentation Thursday 17 November

Targovax
Posted on: 08 Nov 16

Oslo, Norway, 8 November 2016 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing and commercializing immuno-oncology therapies to target, primarily, treatment-resistant solid tumors, will announce its third quarter 2016 results on Thursday, 17 November 2016. A presentation by Targovax's CEO, Øystein Soug, to investors, analysts and the press will take place in Oslo at 10:00 CET.

 

The results report and the presentation will be available at www.targovax.com in the Investors section from 07:00 CET.

 

Presentation

The presentation will take place at 10:00 CET at:

 

Hotel Continental

Stortingsgaten 24/26

0117 Oslo

 

The presentation will also be webcast live and can be accessed through www.targovax.com.

 

Conference call

At 14:00 CET (08:00 EST) The company will host a telephone conference which will include a presentation of the results, following a Q&A session.  CEO Øystein Soug will present the company.  Call in details can be found below.

 

Call-in numbers:

Norway Toll-Free Number: 800 19 747

Norway Toll Number: +472350 0559

UK Toll-Free Number: 08082370030

UK Toll Number: +442031394830

US Toll-Free Number: 1866 928 7517

US Toll Number: +1 718 873 9077

 

Access code: 23804707#

 

Please make sure to dial in at least 5-10 minutes ahead to complete your registration.

 

See attached list for more dial-in numbers.

http://events.arkadin.com/ev/docs/NE_FEL_Events_International_Access_List.pdf

 

 


 

For further information, please contact:

Renate Birkeli, Investor Relations

Phone: +47 922 61 624

Email: renate.birkeli@targovax.com

 

Media and IR enquires:

Jan Petter Stiff - Crux Advisers (Norway)

Phone: +47 995 13 891

Email: stiff@crux.no

 

Julia Phillips/Simon Conway - FTI Consulting (International)

Phone: +44 20 3727 1000

Email: Targovax@fticonsulting.com

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 08/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.